Clinical use of some hypoglycemic drugs may be associated with the risk of drug-indiced
cholestatic liver damage (DILI). The exact prevalence of this complication is unknown …

The number of cases of drug-induced liver damage (DILI) is about 10% of all adverse drug
reactions (ADRs). Cholestatic variant accounts for 20% to 40% of all DILIs. The development …

Cholestasis, defined as the impairment of bile flow/production, is a wellrecognized
presentation of drug-induced liver disease. There are insufficient data in the United States …

Cholestasis caused by medicinal and chemical agents is an increasingly wellrecognized
cause of liver disease. Although the consequences of cholestatic injury are generally …

Cholestasis resulting from medicinal and chemical agents is an increasingly well-
recognized cause of liver disease. Although the consequences of cholestatic injury are …

Drug-induced liver injury (DILI) poses a significant health and economic burden in the
modern health care system. 1 Despite the advancements in health care, DILI is often a …

Cholestasis caused by medicinal and chemical agents is an increasingly well-recognized
cause of liver disease. Clinical drug-induced cholestatic syndromes producing jaundice and …

Assessment of cholestasis in drug-induced liver injury by di... : Medicine Assessment of
cholestasis in drug-induced liver injury by different methods : Medicine Log in or Register Get …

Drug-induced liver injury (DILI) is an adverse reaction to drugs and other xenobiotics that
can have serious consequences and jeopardise progress in pharmacological therapy. While …

Drugs may cause several overlapping syndromes of cholestasis, the pathophysiological
syndrome resulting from impaired bile flow. These reactions comprise approximately 17% of …